Another recently described mechanism of resistance to venetoclax encompasses the nicotinamide metabolism, prominently orchestrated by the enzyme nicotinamide phosphoribosyl transferase encoded by the NAMPT gene, in relapsed and refractory AML LSCs.13 This evidence concerns the gene NAMPT and acute myeloid leukemia.